Showing 337 results

Filters Content type: News, Editors' picks, About HIV Topic: TB treatment

Active tuberculosis (TB) disease is treated with a combination of antibiotics. Successful treatment usually requires at least six months of therapy, without missing doses. People living with HIV also need to take HIV treatment, but it may be started a few weeks after TB treatment. Care is needed when taking TB and HIV treatment at the same time.

Drug-resistant TB

Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Editor's pick
Médecins Sans Frontières
24 March 2016
TB treatment

Statins cut tuberculosis treatment time in mice

Editor's pick
EurekAlert (press release)
16 March 2016
TB treatment

Empirical TB treatment comes up short again

News
26 February 2016
TB treatment

NICE publishes new guideline to better tackle tuberculosis

Editor's pick
NICE press release
15 January 2016
Drug-resistant TB

MDR-TB treatment: Six drugs better than five

News
13 January 2016
TB treatment

Unlikely perk of prison life: Free, speedy TB treatment

Editor's pick
Mail & Guardian
12 January 2016
Drug-resistant TB

Xpert MTB/RIF testing has reduced MDR-TB treatment delays in South Africa

News
7 January 2016
TB treatment

WHO Sounds Alarm Over Big Indian Supplier Of Tuberculosis Drugs

Editor's pick
Medical Daily
15 September 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
TB treatment

High-dose rifampicin may shorten time to TB clearance

News
13 April 2015
TB treatment

Ukraine: Concurrent treatment for HIV/TB co-infection breaks up “deadly alliance”

Editor's pick
Science Speaks
30 March 2015
Drug-resistant TB

Final fight pays off, XXDR-TB & HIV patient cured

Editor's pick
DNAIndia
24 March 2015
TB treatment

Lancet: Phase 2b trial results of novel TB regimen show potential to shorten treatment

Editor's pick
Lancet (free registration required)
18 March 2015
TB treatment

CROI 2015: Trial to evaluate the use of health navigators to link HIV/TB patients to care and treatment fails to show positive results

Editor's pick
Science Speaks
26 February 2015
TB treatment

TB drug candidate starts Phase 1 trial — first in six years

Editor's pick
Science Speaks
20 February 2015
TB treatment

ART during tuberculosis therapy reduces mortality risk for people with HIV

News
19 December 2014
TB treatment

TB Alliance Launches Phase 2B Clinical Trial of a Novel TB Drug Regimen that Could Cut Treatment Time by Half or More for a Majority of TB Patients

Editor's pick
TB Alliance
27 October 2014
Drug-resistant TB

Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates

News
27 October 2014
TB treatment

Newly identified marker helps predict tuberculosis complications in HIV patients

Editor's pick
National Institute of Allergy and Infectious Diseases (NIAID) press release
16 October 2014
TB treatment

In HIV/TB coinfection, initiate antiretroviral therapy early

Editor's pick
Monthly Prescribing Reference (MPR)
16 October 2014
TB treatment

What does new drug PaMZ mean for TB and HIV treatment?

Editor's pick
The Guardian
2 September 2014
Drug-resistant TB

Acquired rifampicin resistance more likely in HIV-coinfected patients

Editor's pick
Healio
2 September 2014
Drug-resistant TB

Use of drug susceptibility testing to select therapy improves treatment outcomes in patients with MDR- and XDR-TB

News
13 August 2014
Drug-resistant TB

Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test

News
23 July 2014